Treatment of Multidrug-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem-Susceptible VAP

Garnacho-Montero, J; Ortiz-Leyba, C.; Jiménez-Jiménez, F.J.; Barrero-Almodóvar, A.E.; Garcia-Garmendia, J.L.; Bernabeu-Wittell, M.; Gallego-Lara, S.L.; Madrazo-Osuna, J.
May 2003
Clinical Infectious Diseases;5/1/2003, Vol. 36 Issue 9, p1111
Academic Journal
We prospectively evaluated the efficacy and toxicity of intravenously administered colistin in 35 episodes of ventilator-associated pneumonia (VAP) due to multidrug-resistant Acinetobacter baumannii. Microbiological diagnosis was performed with use of quantitative culture. In 21 patients, the episodes were caused by a strain susceptible exclusively to colistin (the CO group) and were all treated with this antimicrobial intravenously. In 14 patients, the episodes were caused by strains that remained susceptible to imipenem and were treated with imipenem-cilastatin (the IM group). Acute Physiology and Chronic Health Evaluation II scores at the time of admission and Sequential Organ Failure Assessment scores at time of diagnosis were similar in both groups. VAP was considered clinically cured in 574570360f cases in both groups. In-hospital mortality rates were 61.9 12683120n the CO group and 64.2 12682888n the IM group, and the VAP-related mortality rates were 38and 35.7, respectively. Four patients in the CO group and 6 in the IM group developed renal failure. Neurophysiological evaluation was performed during 12 episodes in the CO group, but it revealed no signs of neuromuscular blockade. Intravenous colistin appears to be a safe and effective alternative to imipenem for the management of VAP due to carbapenem-resistant strains of A. baumannii.


Related Articles

  • Contribution of outer membrane protein K36 to antimicrobial resistance and virulence in Klebsiella pneumoniae. Jiun-Han Chen; Siu, L. K.; Chang-Phone Fung; Jung-Chung Lin; Kuo-Ming Yeh; Te-Li Chen; Yu-Kuo Tsai; Feng-Yee Chang // Journal of Antimicrobial Chemotherapy (JAC);May2010, Vol. 65 Issue 5, p986 

    Objectives: Loss of outer membrane protein (Omp) is commonly encountered in multidrug-resistant Klebsiella pneumoniae. However, little is known about the association between Omp loss and virulence. In the present study, this association was investigated in K. pneumoniae. Methods: An...

  • The Pneumococcus at the Gates. Tomasz, Alexander // New England Journal of Medicine;8/24/95, Vol. 333 Issue 8, p514 

    Editorial. Comments on positive and negative news about pneumococcus. Discussion of a study by Hofmann, et al in the August 24, 1995 issue of the `New England Journal of Medicine'; Penicillin-resistant and multidrug-resistant pneumococci.

  • Diversity of Penicillin-Nonsusceptible Streptococcus pneumoniae Circulating in Iceland after the Introduction of Penicillin-Resistant Clone Spain 6B -2. Sa-Leao, Raquel; Vilhelmsson, Sigurdur E.; de Lencastre, Herminia; Kristinsson, Karl G.; Tomasz, Alexander // Journal of Infectious Diseases;10/1/2002, Vol. 186 Issue 7, p966 

    After the introduction and extensive dissemination of the multidrug-resistant Streptococcus pneumoniae clone Spain[sup 6B]-2 between 1989 and the early to mid-1990s, the prevalence of pneumococcal isolates expressing intermediate resistance to penicillin, mainly of capsular types 6, 19, and 23,...

  • Multidrug Resistance Among Streptococcus pneumoniae Isolated at a University Hospital in Eastern Tennessee. Baddour, Larry M.; Smith, Ernest A. // Clinical Infectious Diseases;7/1/99, Vol. 29 Issue 1, p224 

    Reports the result of a survey on multidrug resistance among patients with Streptococcus pneumoniae at the University of Tennessee Medical Center at Knoxville.

  • Functional assay of multidrug resistant cells using JC-1, a carbocyanine fluorescent probe. Kühnel, J M; Perrot, J Y; Faussat, A M; Marie, J P; Schwaller, M A // Leukemia (08876924);Jul97, Vol. 11 Issue 7, p1147 

    Multidrug resistance (MDR) is characterized by a decrease in the efficiency of chemotherapeutic agents correlated with the expression and activity of a membrane protein: the permeability-glycoprotein (Pgp 170). Clinically, detection of MDR can be performed by functional tests based on the...

  • Microbiology of healthcare-associated infections and the definition accuracy to predict infection by potentially drug resistant pathogens: a systematic review. Cardoso, Teresa; Almeida, Mónica; Carratalà, Jordi; Aragão, Irene; Costa-Pereira, Altamiro; Sarmento, António E.; Azevedo, Luís // BMC Infectious Diseases;12/11/2015, Vol. 15, p1 

    Background: Healthcare-associated infections (HCAI) represent up to 50 % of all infections among patients admitted from the community. The current review intends to provide a systematic review on the microbiological profile involved in HCAI, to compare it with community-acquired...

  • Genomic Definition of Hypervirulent and Multidrug-Resistant Klebsiella pneumoniae Clonal Groups. Bialek-Davenet, Suzanne; Criscuolo, Alexis; Ailloud, Florent; Passet, Virginie; Jones, Louis; Delannoy-Vieillard, Anne-Sophie; Garin, Benoit; Le Hello, Simon; Arlet, Guillaume; Nicolas-Chanoine, Marie-Hélène; Decré, Dominique; Brisse, Sylvain // Emerging Infectious Diseases;Nov2014, Vol. 20 Issue 11, p1812 

    Multidrug-resistant and highly virulent Klebsiella pneumoniae isolates are emerging, but the clonal groups (CGs) corresponding to these high-risk strains have remained imprecisely defined. We aimed to identify K. pneumoniae CGs on the basis of genome-wide sequence variation and to provide a...

  • Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa. Abdelraouf, Kamilia; Kabbara, Samer; Ledesma, Kimberly R.; Poole, Keith; Tam, Vincent H. // Journal of Antimicrobial Chemotherapy (JAC);Jun2011, Vol. 66 Issue 6, p1311 

    Background Multidrug resistance has become a quandary in the treatment of bacterial infections. The effect of resistance mutations and the fitness cost on the pathogenicity of Pseudomonas aeruginosa is not well established. The objective of this study was to examine the impact of multidrug...

  • Antibiotic Selection of Multiply Resistant Pneumococci. Klugman, Keith P. // Clinical Infectious Diseases;8/15/2001, Vol. 33 Issue 4, p489 

    Deals with the selection of multiply resistant bacteria. Definition of multiple-antibiotic resistance; Selective advantages of multiple-antibiotic-resistant strains over strains resistant to just one antibiotic; Factors that have an important role in the selection of bacterial species that can...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics